MHC
HAE icon

May Hill Capital’s Haemonetics HAE Stock Holding History

May Hill Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26M Hold
22,348
– – 0.32% 65
2025
Q4 		$1.79M Hold
22,348
– – 0.48% 41
2025
Q3 		$1.09M Buy
22,348
+4,431
+25% +$274K 0.32% 53
2025
Q2 		$1.34M Sell
17,917
-23
-0.1% -$1.52K 0.44% 44
2025
Q1 		$1.14M Buy
17,940
+25
+0.1% +$1.7K 0.43% 41
2024
Q4 		$1.4M Buy
+17,915
New +$1.44M 0.54% 31

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

May Hill Capital's HAE Position: Q1 2026 in Review

May Hill Capital held its Haemonetics (HAE) position steady in Q1 2026 at 22,348 shares worth $1.26M. The position accounts for 0.32% of the portfolio, ranked #65.

May Hill Capital first reported a position in HAE in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.79M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • May Hill Capital held 22,348 shares of Haemonetics worth $1.26M as of Q1 2026.
  • May Hill Capital left its Haemonetics share count unchanged in Q1 2026.
  • Haemonetics made up 0.32% of May Hill Capital's portfolio in Q1 2026, its #65 holding.
  • May Hill Capital first reported a position in Haemonetics in Q4 2024 and has held it in 6 quarters since.
  • May Hill Capital's Haemonetics position peaked at $1.79M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.